Epidemiology, biologic behavior, and natural history of mesothelioma.
about
Residential proximity to naturally occurring asbestos and mesothelioma risk in CaliforniaFibulin-3 as a biomarker of response to treatment in malignant mesotheliomaMultiple malignant epithelioid mesotheliomas of the liver and greater omentum: a case report and review of the literatureNovel therapies in phase II and III trials for malignant pleural mesothelioma.The application of cold-plasma coagulation on the visceral pleura results in a predictable depth of necrosis without fistula generation.Ranpirnase--an antitumour ribonuclease: its potential role in malignant mesothelioma.Animal models of malignant mesothelioma.Asbestos burden predicts survival in pleural mesothelioma.Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural MesotheliomaGemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810)A Novel Panel of Serum Biomarkers for MPM Diagnosis.The evolution of multimodality therapy for malignant pleural mesotheliomaFactors affecting soluble mesothelin related protein levels in an asbestos-exposed population.Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.Cold-plasma coagulation in the treatment of malignant pleural mesothelioma: results of a combined approach.Role of new radiation techniques in the treatment of pleural mesothelioma.The clinicopathological characteristics with long-term outcomes in malignant mesothelioma.FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival.Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos.The Influence of Genetic Variability on the Risk of Developing Malignant Mesothelioma.
P2860
Q23923965-88A4DD3C-B3D0-401C-87FB-9B0B89F33AD7Q28389185-86720FE5-9D9F-486B-81C8-6DF29A289ACAQ33658474-94CA09C2-455F-4DDB-8AB7-F436C719D03BQ35129535-E194A08E-B0A7-4571-A382-0C7C4000AC2DQ35790037-77891A26-52FB-4BE1-9083-AB1361239ED8Q36425940-B412571A-8B75-4EA4-AC45-81D17260CD01Q36571864-7DE0D490-EF77-4A10-B0F5-D8C54F95C6F2Q36725369-E6A3D4C7-747A-45D6-98BE-5500DEA542B5Q36822118-2461911D-1DF5-45BE-8D6F-6824C5DDAE2FQ37029331-32F9B842-6470-4BE1-AC86-28DB24C44A38Q37243005-CB079D82-E995-4E71-8532-EF6189F9FD00Q37699936-E951323A-4A93-4E0A-9135-9D0F73FCCA23Q42019544-8DDD3064-046C-4A34-99C1-B01233F702F0Q43117575-503820F2-A14F-41B0-8066-E21C67AF9E4FQ48254799-087F5252-DC4B-4BBD-8933-26EC3D6D6FE1Q48909660-BA72753E-AEB1-4717-8778-A8425CAF84D0Q50050392-733785DB-3BF6-4D59-B1C7-30DB90ECA364Q51114246-587DBD8B-ECAC-4BA9-AB57-E7A56C1A74A9Q51617036-D6C69DEC-7B28-4025-BD27-3D9365005D70Q54678404-B20E1196-4EFE-4C46-99E6-55E2D4089911Q55073051-F0802B31-4F0B-46FD-8DEF-C926DC38922B
P2860
Epidemiology, biologic behavior, and natural history of mesothelioma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Epidemiology, biologic behavior, and natural history of mesothelioma.
@ast
Epidemiology, biologic behavior, and natural history of mesothelioma.
@en
type
label
Epidemiology, biologic behavior, and natural history of mesothelioma.
@ast
Epidemiology, biologic behavior, and natural history of mesothelioma.
@en
prefLabel
Epidemiology, biologic behavior, and natural history of mesothelioma.
@ast
Epidemiology, biologic behavior, and natural history of mesothelioma.
@en
P1476
Epidemiology, biologic behavior, and natural history of mesothelioma.
@en
P2093
David C Christiani
Lambros Zellos
P304
469-77, viii
P356
10.1016/J.THORSURG.2004.06.011
P577
2004-11-01T00:00:00Z